The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
1Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Data Availability
All data are included in the manuscript
Posted June 08, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (161)
- Allergy and Immunology (416)
- Anesthesia (91)
- Cardiovascular Medicine (860)
- Dermatology (97)
- Emergency Medicine (250)
- Epidemiology (8562)
- Gastroenterology (384)
- Genetic and Genomic Medicine (1753)
- Geriatric Medicine (167)
- Health Economics (373)
- Health Informatics (1244)
- Health Policy (621)
- Hematology (196)
- HIV/AIDS (374)
- Medical Education (192)
- Medical Ethics (51)
- Nephrology (212)
- Neurology (1678)
- Nursing (97)
- Nutrition (251)
- Oncology (929)
- Ophthalmology (263)
- Orthopedics (102)
- Otolaryngology (172)
- Pain Medicine (114)
- Palliative Medicine (40)
- Pathology (253)
- Pediatrics (536)
- Primary Care Research (208)
- Public and Global Health (3841)
- Radiology and Imaging (624)
- Respiratory Medicine (520)
- Rheumatology (208)
- Sports Medicine (158)
- Surgery (190)
- Toxicology (36)
- Transplantation (101)
- Urology (76)